DIAGREAT-MEDICA IN GERMANY
Recently, the 56th International Medical and Medical Devices Expo (2024 MEDICA) was successfully concluded in Düsseldorf, Germany. Diagreat brought its advanced chemiluminescence products and technologies to the exhibition, competing with global outstanding enterprises, and attracting wide attention with its innovative IVD solutions!
Diagreat Showing the Strength of Chinese Brands
Diagreat, as an innovator in the in vitro diagnostics (IVD) industry, has a comprehensive IVD solution. The solution covers from the core supply of reagent raw materials, to comprehensive reagent solutions, to high-precision detection instrument platforms. Diagreat has made technological breakthroughs, realizing efficient detection of small molecule chemical drugs and biologics on the same platform, with excellent performance in sensitivity, specificity and stability, providing a better choice for global healthcare organizations.
Diagreat has a number of domestic and international in vitro diagnostic product registration certificates, and its core product lines include POCT series, biochemistry series, chemiluminescence series, among which the Therapeutic drug monitoring(TDM) series products have unique advantages. With the significant advantages of fully automated, quantitative, fast and accurate, complete items and common platform, Diagreat has won the trust of customers. Diagreat's products have not only passed the CE certification of the European Union, but also obtained the certification of Italy, Mexico and Ecuador, and have been successfully sold to more than 60 countries and regions around the world.
At the booth of Diagreat, we had in-depth communication with the customers who came to consult with us, understood their needs in detail, and provided personalized solutions for them. Many customers said that Diagreat's products and technologies have left a deep impression on them and look forward to further cooperation.
2024 MEDICA concludes successfully
Diagreat will continue to increase investment in research and development, improve product quality, drive development with innovation, and contribute to the global healthcare industry. We firmly believe that with the joint efforts of Diagreat and other outstanding enterprises, China's IVD industry will continue to move to new heights and provide more high-quality and efficient medical solutions for global customers.
Finally, thanks to all the friends who have paid attention to and supported Diagreat, let's look forward to Diagreat blooming even more brilliantly in the international arena!